nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—ADRB2—prostate cancer	0.152	0.646	CbGaD
Mirtazapine—CYP3A4—prostate cancer	0.0833	0.354	CbGaD
Mirtazapine—CYP2C8—Nilutamide—prostate cancer	0.0305	0.0784	CbGbCtD
Mirtazapine—CYP2C8—Abiraterone—prostate cancer	0.0253	0.0649	CbGbCtD
Mirtazapine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0236	0.0605	CbGbCtD
Mirtazapine—CYP2C9—Bicalutamide—prostate cancer	0.0213	0.0547	CbGbCtD
Mirtazapine—CYP2C9—Nilutamide—prostate cancer	0.0213	0.0547	CbGbCtD
Mirtazapine—CYP1A2—Flutamide—prostate cancer	0.0196	0.0503	CbGbCtD
Mirtazapine—CYP2D6—Bicalutamide—prostate cancer	0.0195	0.05	CbGbCtD
Mirtazapine—CYP2C8—Cabazitaxel—prostate cancer	0.0187	0.048	CbGbCtD
Mirtazapine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0163	0.0418	CbGbCtD
Mirtazapine—CYP2D6—Abiraterone—prostate cancer	0.0161	0.0414	CbGbCtD
Mirtazapine—CYP1A2—Estrone—prostate cancer	0.0141	0.0363	CbGbCtD
Mirtazapine—CYP2C9—Estrone—prostate cancer	0.0127	0.0327	CbGbCtD
Mirtazapine—CYP3A4—Bicalutamide—prostate cancer	0.0124	0.0318	CbGbCtD
Mirtazapine—CYP3A4—Estramustine—prostate cancer	0.0115	0.0295	CbGbCtD
Mirtazapine—CYP2C8—Estradiol—prostate cancer	0.0105	0.027	CbGbCtD
Mirtazapine—CYP3A4—Abiraterone—prostate cancer	0.0103	0.0263	CbGbCtD
Mirtazapine—CYP3A4—Flutamide—prostate cancer	0.0103	0.0263	CbGbCtD
Mirtazapine—CYP2C9—Capecitabine—prostate cancer	0.00966	0.0248	CbGbCtD
Mirtazapine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00925	0.0238	CbGbCtD
Mirtazapine—HTR7—vas deferens—prostate cancer	0.00837	0.253	CbGeAlD
Mirtazapine—CYP1A2—Estradiol—prostate cancer	0.00812	0.0209	CbGbCtD
Mirtazapine—CYP3A4—Cabazitaxel—prostate cancer	0.00758	0.0195	CbGbCtD
Mirtazapine—CYP3A4—Estrone—prostate cancer	0.00741	0.019	CbGbCtD
Mirtazapine—CYP2C9—Estradiol—prostate cancer	0.00732	0.0188	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—prostate cancer	0.00685	0.0176	CbGbCtD
Mirtazapine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00661	0.017	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—prostate cancer	0.0053	0.0136	CbGbCtD
Mirtazapine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00485	0.0125	CbGbCtD
Mirtazapine—CYP3A4—Mitoxantrone—prostate cancer	0.00441	0.0113	CbGbCtD
Mirtazapine—CYP3A4—Estradiol—prostate cancer	0.00426	0.0109	CbGbCtD
Mirtazapine—CYP3A4—Prednisone—prostate cancer	0.00366	0.0094	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—prostate cancer	0.00298	0.00766	CbGbCtD
Mirtazapine—CYP3A4—Etoposide—prostate cancer	0.00278	0.00714	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—prostate cancer	0.00254	0.00653	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—prostate cancer	0.0019	0.00487	CbGbCtD
Mirtazapine—CYP1A2—urine—prostate cancer	0.00166	0.0503	CbGeAlD
Mirtazapine—CYP2C9—urine—prostate cancer	0.00158	0.0477	CbGeAlD
Mirtazapine—OPRK1—prostate gland—prostate cancer	0.00149	0.0451	CbGeAlD
Mirtazapine—HTR2A—urine—prostate cancer	0.0013	0.0393	CbGeAlD
Mirtazapine—CYP3A4—urine—prostate cancer	0.0012	0.0364	CbGeAlD
Mirtazapine—CYP2D6—urine—prostate cancer	0.00118	0.0358	CbGeAlD
Mirtazapine—DRD4—testis—prostate cancer	0.00105	0.0317	CbGeAlD
Mirtazapine—ADRB1—prostate gland—prostate cancer	0.000912	0.0276	CbGeAlD
Mirtazapine—ADRA1A—prostate gland—prostate cancer	0.000721	0.0218	CbGeAlD
Mirtazapine—ADRA2C—prostate gland—prostate cancer	0.000687	0.0208	CbGeAlD
Mirtazapine—ADRA2C—seminal vesicle—prostate cancer	0.000581	0.0176	CbGeAlD
Mirtazapine—HRH1—prostate gland—prostate cancer	0.000558	0.0169	CbGeAlD
Mirtazapine—HTR7—epithelium—prostate cancer	0.000549	0.0166	CbGeAlD
Mirtazapine—ADRA2A—prostate gland—prostate cancer	0.000548	0.0166	CbGeAlD
Mirtazapine—HTR1A—renal system—prostate cancer	0.000533	0.0161	CbGeAlD
Mirtazapine—ADRA1A—epithelium—prostate cancer	0.00053	0.016	CbGeAlD
Mirtazapine—HTR7—renal system—prostate cancer	0.000509	0.0154	CbGeAlD
Mirtazapine—ADRA1A—renal system—prostate cancer	0.000491	0.0149	CbGeAlD
Mirtazapine—ADRA2C—renal system—prostate cancer	0.000468	0.0142	CbGeAlD
Mirtazapine—ADRA2A—seminal vesicle—prostate cancer	0.000464	0.014	CbGeAlD
Mirtazapine—ADRA2C—urethra—prostate cancer	0.00046	0.0139	CbGeAlD
Mirtazapine—CYP2C8—renal system—prostate cancer	0.000434	0.0131	CbGeAlD
Mirtazapine—SLC6A3—testis—prostate cancer	0.000423	0.0128	CbGeAlD
Mirtazapine—HRH1—epithelium—prostate cancer	0.00041	0.0124	CbGeAlD
Mirtazapine—CYP1A2—renal system—prostate cancer	0.000406	0.0123	CbGeAlD
Mirtazapine—HRH1—urethra—prostate cancer	0.000374	0.0113	CbGeAlD
Mirtazapine—ADRA2A—urethra—prostate cancer	0.000367	0.0111	CbGeAlD
Mirtazapine—HTR2A—epithelium—prostate cancer	0.000343	0.0104	CbGeAlD
Mirtazapine—SLC6A2—testis—prostate cancer	0.000342	0.0103	CbGeAlD
Mirtazapine—HTR7—testis—prostate cancer	0.000329	0.00997	CbGeAlD
Mirtazapine—HTR2A—renal system—prostate cancer	0.000318	0.00961	CbGeAlD
Mirtazapine—DRD2—testis—prostate cancer	0.000311	0.00942	CbGeAlD
Mirtazapine—ADRA2C—testis—prostate cancer	0.000303	0.00916	CbGeAlD
Mirtazapine—CYP3A4—renal system—prostate cancer	0.000294	0.0089	CbGeAlD
Mirtazapine—CYP2D6—renal system—prostate cancer	0.000289	0.00876	CbGeAlD
Mirtazapine—CYP2C8—testis—prostate cancer	0.000281	0.00849	CbGeAlD
Mirtazapine—HTR2B—lymph node—prostate cancer	0.000279	0.00844	CbGeAlD
Mirtazapine—SLC6A2—lymph node—prostate cancer	0.000248	0.00749	CbGeAlD
Mirtazapine—HRH1—testis—prostate cancer	0.000246	0.00744	CbGeAlD
Mirtazapine—ADRA2A—testis—prostate cancer	0.000242	0.00731	CbGeAlD
Mirtazapine—ADRA2C—lymph node—prostate cancer	0.000219	0.00664	CbGeAlD
Mirtazapine—HTR2A—testis—prostate cancer	0.000205	0.00621	CbGeAlD
Mirtazapine—CYP2D6—testis—prostate cancer	0.000187	0.00566	CbGeAlD
Mirtazapine—HRH1—lymph node—prostate cancer	0.000178	0.00539	CbGeAlD
Mirtazapine—ADRA2A—lymph node—prostate cancer	0.000175	0.0053	CbGeAlD
Mirtazapine—Rash—Mitoxantrone—prostate cancer	3.05e-05	0.000138	CcSEcCtD
Mirtazapine—Dermatitis—Mitoxantrone—prostate cancer	3.05e-05	0.000138	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.05e-05	0.000138	CcSEcCtD
Mirtazapine—Headache—Mitoxantrone—prostate cancer	3.03e-05	0.000137	CcSEcCtD
Mirtazapine—Hypotension—Capecitabine—prostate cancer	3.03e-05	0.000137	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—prostate cancer	3.02e-05	0.000137	CcSEcCtD
Mirtazapine—Myalgia—Prednisone—prostate cancer	3.01e-05	0.000136	CcSEcCtD
Mirtazapine—Arthralgia—Prednisone—prostate cancer	3.01e-05	0.000136	CcSEcCtD
Mirtazapine—Paraesthesia—Docetaxel—prostate cancer	3e-05	0.000136	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—prostate cancer	3e-05	0.000136	CcSEcCtD
Mirtazapine—Anxiety—Prednisone—prostate cancer	3e-05	0.000136	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—prostate cancer	2.99e-05	0.000135	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.99e-05	0.000135	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—prostate cancer	2.98e-05	0.000135	CcSEcCtD
Mirtazapine—Somnolence—Docetaxel—prostate cancer	2.97e-05	0.000135	CcSEcCtD
Mirtazapine—Discomfort—Prednisone—prostate cancer	2.97e-05	0.000135	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—prostate cancer	2.97e-05	0.000134	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—prostate cancer	2.96e-05	0.000134	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—prostate cancer	2.96e-05	0.000134	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.95e-05	0.000134	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—prostate cancer	2.95e-05	0.000133	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—prostate cancer	2.95e-05	0.000133	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—prostate cancer	2.94e-05	0.000133	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—prostate cancer	2.94e-05	0.000133	CcSEcCtD
Mirtazapine—Insomnia—Capecitabine—prostate cancer	2.93e-05	0.000133	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—prostate cancer	2.92e-05	0.000132	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—prostate cancer	2.92e-05	0.000132	CcSEcCtD
Mirtazapine—Paraesthesia—Capecitabine—prostate cancer	2.91e-05	0.000132	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—prostate cancer	2.91e-05	0.000132	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—prostate cancer	2.9e-05	0.000131	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—prostate cancer	2.89e-05	0.000131	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.89e-05	0.000131	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—prostate cancer	2.89e-05	0.000131	CcSEcCtD
Mirtazapine—Dyspnoea—Capecitabine—prostate cancer	2.89e-05	0.000131	CcSEcCtD
Mirtazapine—Oedema—Prednisone—prostate cancer	2.88e-05	0.000131	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—prostate cancer	2.88e-05	0.000131	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—prostate cancer	2.88e-05	0.00013	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—prostate cancer	2.88e-05	0.00013	CcSEcCtD
Mirtazapine—Nausea—Mitoxantrone—prostate cancer	2.87e-05	0.00013	CcSEcCtD
Mirtazapine—Infection—Prednisone—prostate cancer	2.87e-05	0.00013	CcSEcCtD
Mirtazapine—Pain—Docetaxel—prostate cancer	2.86e-05	0.00013	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—prostate cancer	2.86e-05	0.00013	CcSEcCtD
Mirtazapine—Dyspepsia—Capecitabine—prostate cancer	2.85e-05	0.000129	CcSEcCtD
Mirtazapine—Chills—Epirubicin—prostate cancer	2.85e-05	0.000129	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—prostate cancer	2.85e-05	0.000129	CcSEcCtD
Mirtazapine—Shock—Prednisone—prostate cancer	2.84e-05	0.000129	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—prostate cancer	2.84e-05	0.000128	CcSEcCtD
Mirtazapine—Nervous system disorder—Prednisone—prostate cancer	2.83e-05	0.000128	CcSEcCtD
Mirtazapine—Tachycardia—Prednisone—prostate cancer	2.81e-05	0.000128	CcSEcCtD
Mirtazapine—Decreased appetite—Capecitabine—prostate cancer	2.81e-05	0.000128	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—prostate cancer	2.81e-05	0.000127	CcSEcCtD
Mirtazapine—Skin disorder—Prednisone—prostate cancer	2.8e-05	0.000127	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.8e-05	0.000127	CcSEcCtD
Mirtazapine—Fatigue—Capecitabine—prostate cancer	2.79e-05	0.000126	CcSEcCtD
Mirtazapine—Hyperhidrosis—Prednisone—prostate cancer	2.79e-05	0.000126	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—prostate cancer	2.78e-05	0.000126	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—prostate cancer	2.78e-05	0.000126	CcSEcCtD
Mirtazapine—Constipation—Capecitabine—prostate cancer	2.77e-05	0.000125	CcSEcCtD
Mirtazapine—Pain—Capecitabine—prostate cancer	2.77e-05	0.000125	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—prostate cancer	2.76e-05	0.000125	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—prostate cancer	2.76e-05	0.000125	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—prostate cancer	2.75e-05	0.000125	CcSEcCtD
Mirtazapine—Anorexia—Prednisone—prostate cancer	2.75e-05	0.000125	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—prostate cancer	2.75e-05	0.000124	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—prostate cancer	2.74e-05	0.000124	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—prostate cancer	2.73e-05	0.000124	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—prostate cancer	2.73e-05	0.000124	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—prostate cancer	2.72e-05	0.000123	CcSEcCtD
Mirtazapine—Tension—Epirubicin—prostate cancer	2.71e-05	0.000123	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—prostate cancer	2.71e-05	0.000123	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—prostate cancer	2.68e-05	0.000122	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—prostate cancer	2.67e-05	0.000121	CcSEcCtD
Mirtazapine—Feeling abnormal—Capecitabine—prostate cancer	2.67e-05	0.000121	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—prostate cancer	2.67e-05	0.000121	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—prostate cancer	2.66e-05	0.000121	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Capecitabine—prostate cancer	2.65e-05	0.00012	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—prostate cancer	2.64e-05	0.00012	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—prostate cancer	2.64e-05	0.00012	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—prostate cancer	2.64e-05	0.000119	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.63e-05	0.000119	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—prostate cancer	2.62e-05	0.000119	CcSEcCtD
Mirtazapine—Insomnia—Prednisone—prostate cancer	2.61e-05	0.000118	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—prostate cancer	2.6e-05	0.000118	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisone—prostate cancer	2.59e-05	0.000117	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—prostate cancer	2.57e-05	0.000117	CcSEcCtD
Mirtazapine—Urticaria—Capecitabine—prostate cancer	2.57e-05	0.000117	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—prostate cancer	2.56e-05	0.000116	CcSEcCtD
Mirtazapine—Abdominal pain—Capecitabine—prostate cancer	2.56e-05	0.000116	CcSEcCtD
Mirtazapine—Body temperature increased—Capecitabine—prostate cancer	2.56e-05	0.000116	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—prostate cancer	2.56e-05	0.000116	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—prostate cancer	2.56e-05	0.000116	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—prostate cancer	2.55e-05	0.000116	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—prostate cancer	2.54e-05	0.000115	CcSEcCtD
Mirtazapine—Dyspepsia—Prednisone—prostate cancer	2.54e-05	0.000115	CcSEcCtD
Mirtazapine—Rash—Etoposide—prostate cancer	2.54e-05	0.000115	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—prostate cancer	2.54e-05	0.000115	CcSEcCtD
Mirtazapine—Headache—Etoposide—prostate cancer	2.52e-05	0.000114	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—prostate cancer	2.52e-05	0.000114	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—prostate cancer	2.51e-05	0.000114	CcSEcCtD
Mirtazapine—Decreased appetite—Prednisone—prostate cancer	2.51e-05	0.000114	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—prostate cancer	2.5e-05	0.000113	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—prostate cancer	2.49e-05	0.000113	CcSEcCtD
Mirtazapine—Fatigue—Prednisone—prostate cancer	2.49e-05	0.000113	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—prostate cancer	2.48e-05	0.000113	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—prostate cancer	2.48e-05	0.000112	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—prostate cancer	2.48e-05	0.000112	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—prostate cancer	2.47e-05	0.000112	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—prostate cancer	2.47e-05	0.000112	CcSEcCtD
Mirtazapine—Constipation—Prednisone—prostate cancer	2.47e-05	0.000112	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—prostate cancer	2.46e-05	0.000112	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—prostate cancer	2.44e-05	0.000111	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—prostate cancer	2.43e-05	0.00011	CcSEcCtD
Mirtazapine—Cough—Epirubicin—prostate cancer	2.41e-05	0.000109	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—prostate cancer	2.4e-05	0.000109	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—prostate cancer	2.39e-05	0.000108	CcSEcCtD
Mirtazapine—Nausea—Etoposide—prostate cancer	2.39e-05	0.000108	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—prostate cancer	2.39e-05	0.000108	CcSEcCtD
Mirtazapine—Hypersensitivity—Capecitabine—prostate cancer	2.39e-05	0.000108	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisone—prostate cancer	2.38e-05	0.000108	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—prostate cancer	2.37e-05	0.000107	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—prostate cancer	2.37e-05	0.000107	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—prostate cancer	2.36e-05	0.000107	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Prednisone—prostate cancer	2.36e-05	0.000107	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—prostate cancer	2.35e-05	0.000107	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—prostate cancer	2.35e-05	0.000107	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—prostate cancer	2.35e-05	0.000107	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—prostate cancer	2.35e-05	0.000106	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—prostate cancer	2.34e-05	0.000106	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.34e-05	0.000106	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—prostate cancer	2.32e-05	0.000105	CcSEcCtD
Mirtazapine—Asthenia—Capecitabine—prostate cancer	2.32e-05	0.000105	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—prostate cancer	2.31e-05	0.000104	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—prostate cancer	2.3e-05	0.000104	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—prostate cancer	2.3e-05	0.000104	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—prostate cancer	2.29e-05	0.000104	CcSEcCtD
Mirtazapine—Urticaria—Prednisone—prostate cancer	2.29e-05	0.000104	CcSEcCtD
Mirtazapine—Pruritus—Capecitabine—prostate cancer	2.29e-05	0.000104	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—prostate cancer	2.29e-05	0.000104	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—prostate cancer	2.29e-05	0.000104	CcSEcCtD
Mirtazapine—Abdominal pain—Prednisone—prostate cancer	2.28e-05	0.000103	CcSEcCtD
Mirtazapine—Body temperature increased—Prednisone—prostate cancer	2.28e-05	0.000103	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—prostate cancer	2.27e-05	0.000103	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—prostate cancer	2.26e-05	0.000102	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—prostate cancer	2.26e-05	0.000102	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—prostate cancer	2.25e-05	0.000102	CcSEcCtD
Mirtazapine—Infection—Epirubicin—prostate cancer	2.24e-05	0.000102	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—prostate cancer	2.23e-05	0.000101	CcSEcCtD
Mirtazapine—Shock—Epirubicin—prostate cancer	2.22e-05	0.000101	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—prostate cancer	2.22e-05	0.0001	CcSEcCtD
Mirtazapine—Diarrhoea—Capecitabine—prostate cancer	2.22e-05	0.0001	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—prostate cancer	2.21e-05	0.0001	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—prostate cancer	2.21e-05	0.0001	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—prostate cancer	2.21e-05	0.0001	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—prostate cancer	2.21e-05	0.0001	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—prostate cancer	2.2e-05	9.97e-05	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—prostate cancer	2.19e-05	9.93e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—prostate cancer	2.18e-05	9.88e-05	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—prostate cancer	2.18e-05	9.86e-05	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—prostate cancer	2.18e-05	9.86e-05	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—prostate cancer	2.18e-05	9.86e-05	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—prostate cancer	2.17e-05	9.83e-05	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.16e-05	9.8e-05	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—prostate cancer	2.15e-05	9.74e-05	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—prostate cancer	2.15e-05	9.74e-05	CcSEcCtD
Mirtazapine—Dizziness—Capecitabine—prostate cancer	2.14e-05	9.7e-05	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—prostate cancer	2.13e-05	9.65e-05	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—prostate cancer	2.13e-05	9.63e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisone—prostate cancer	2.12e-05	9.63e-05	CcSEcCtD
Mirtazapine—Rash—Docetaxel—prostate cancer	2.11e-05	9.55e-05	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—prostate cancer	2.11e-05	9.55e-05	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—prostate cancer	2.11e-05	9.54e-05	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—prostate cancer	2.1e-05	9.53e-05	CcSEcCtD
Mirtazapine—Headache—Docetaxel—prostate cancer	2.1e-05	9.49e-05	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—prostate cancer	2.09e-05	9.46e-05	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—prostate cancer	2.07e-05	9.39e-05	CcSEcCtD
Mirtazapine—Asthenia—Prednisone—prostate cancer	2.07e-05	9.37e-05	CcSEcCtD
Mirtazapine—Vomiting—Capecitabine—prostate cancer	2.06e-05	9.33e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.06e-05	9.31e-05	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—prostate cancer	2.05e-05	9.3e-05	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—prostate cancer	2.05e-05	9.27e-05	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—prostate cancer	2.04e-05	9.26e-05	CcSEcCtD
Mirtazapine—Rash—Capecitabine—prostate cancer	2.04e-05	9.25e-05	CcSEcCtD
Mirtazapine—Pruritus—Prednisone—prostate cancer	2.04e-05	9.24e-05	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—prostate cancer	2.04e-05	9.24e-05	CcSEcCtD
Mirtazapine—Dermatitis—Capecitabine—prostate cancer	2.04e-05	9.24e-05	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—prostate cancer	2.04e-05	9.23e-05	CcSEcCtD
Mirtazapine—Headache—Capecitabine—prostate cancer	2.03e-05	9.19e-05	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—prostate cancer	2.03e-05	9.18e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—prostate cancer	2.03e-05	9.18e-05	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—prostate cancer	2.02e-05	9.14e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—prostate cancer	2.01e-05	9.11e-05	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—prostate cancer	2.01e-05	9.08e-05	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—prostate cancer	1.99e-05	9.01e-05	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—prostate cancer	1.99e-05	9e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—prostate cancer	1.99e-05	9e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Prednisone—prostate cancer	1.97e-05	8.94e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—prostate cancer	1.96e-05	8.88e-05	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—prostate cancer	1.95e-05	8.84e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.95e-05	8.82e-05	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—prostate cancer	1.94e-05	8.81e-05	CcSEcCtD
Mirtazapine—Pain—Epirubicin—prostate cancer	1.93e-05	8.74e-05	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—prostate cancer	1.93e-05	8.74e-05	CcSEcCtD
Mirtazapine—Nausea—Capecitabine—prostate cancer	1.92e-05	8.71e-05	CcSEcCtD
Mirtazapine—Dizziness—Prednisone—prostate cancer	1.91e-05	8.64e-05	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.9e-05	8.61e-05	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—prostate cancer	1.89e-05	8.55e-05	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—prostate cancer	1.87e-05	8.49e-05	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—prostate cancer	1.86e-05	8.43e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—prostate cancer	1.86e-05	8.42e-05	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—prostate cancer	1.86e-05	8.41e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—prostate cancer	1.84e-05	8.36e-05	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—prostate cancer	1.84e-05	8.32e-05	CcSEcCtD
Mirtazapine—Vomiting—Prednisone—prostate cancer	1.83e-05	8.31e-05	CcSEcCtD
Mirtazapine—Rash—Prednisone—prostate cancer	1.82e-05	8.24e-05	CcSEcCtD
Mirtazapine—Dermatitis—Prednisone—prostate cancer	1.82e-05	8.23e-05	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—prostate cancer	1.81e-05	8.22e-05	CcSEcCtD
Mirtazapine—Headache—Prednisone—prostate cancer	1.81e-05	8.19e-05	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.8e-05	8.16e-05	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—prostate cancer	1.8e-05	8.15e-05	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—prostate cancer	1.79e-05	8.12e-05	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—prostate cancer	1.78e-05	8.09e-05	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—prostate cancer	1.78e-05	8.09e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—prostate cancer	1.78e-05	8.08e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—prostate cancer	1.78e-05	8.08e-05	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—prostate cancer	1.72e-05	7.79e-05	CcSEcCtD
Mirtazapine—Nausea—Prednisone—prostate cancer	1.71e-05	7.76e-05	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.71e-05	7.73e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—prostate cancer	1.66e-05	7.53e-05	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—prostate cancer	1.66e-05	7.51e-05	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—prostate cancer	1.65e-05	7.47e-05	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—prostate cancer	1.65e-05	7.47e-05	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—prostate cancer	1.62e-05	7.33e-05	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—prostate cancer	1.6e-05	7.23e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—prostate cancer	1.54e-05	6.99e-05	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—prostate cancer	1.54e-05	6.97e-05	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—prostate cancer	1.5e-05	6.78e-05	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—prostate cancer	1.49e-05	6.76e-05	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—prostate cancer	1.48e-05	6.69e-05	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—prostate cancer	1.43e-05	6.5e-05	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—prostate cancer	1.43e-05	6.47e-05	CcSEcCtD
Mirtazapine—Rash—Epirubicin—prostate cancer	1.42e-05	6.44e-05	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—prostate cancer	1.42e-05	6.44e-05	CcSEcCtD
Mirtazapine—Headache—Epirubicin—prostate cancer	1.41e-05	6.4e-05	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—prostate cancer	1.38e-05	6.25e-05	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—prostate cancer	1.34e-05	6.07e-05	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—prostate cancer	1.33e-05	6.01e-05	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—prostate cancer	1.32e-05	5.96e-05	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—prostate cancer	1.31e-05	5.96e-05	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—prostate cancer	1.31e-05	5.92e-05	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—prostate cancer	1.24e-05	5.62e-05	CcSEcCtD
Mirtazapine—HTR1A—Signaling Pathways—SRC—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—RXRA—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EP300—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SRC—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—prostate cancer	1.35e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—prostate cancer	1.34e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARA—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—prostate cancer	1.34e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—prostate cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—prostate cancer	1.33e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—prostate cancer	1.33e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.33e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.33e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	1.32e-06	1.09e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.32e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.32e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—prostate cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—prostate cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—prostate cancer	1.31e-06	1.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.31e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—prostate cancer	1.31e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.3e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—COMT—prostate cancer	1.3e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—prostate cancer	1.3e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	1.29e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.29e-06	1.07e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—prostate cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—prostate cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—prostate cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—prostate cancer	1.28e-06	1.06e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.28e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—INS—prostate cancer	1.28e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.28e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	1.28e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—INS—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAV1—prostate cancer	1.26e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—prostate cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.24e-06	1.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.23e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—prostate cancer	1.23e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.23e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—prostate cancer	1.23e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.23e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—prostate cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.22e-06	1e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—prostate cancer	1.21e-06	9.99e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.21e-06	9.99e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—prostate cancer	1.21e-06	9.99e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.21e-06	9.96e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.21e-06	9.93e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.21e-06	9.92e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.2e-06	9.91e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—prostate cancer	1.2e-06	9.9e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—prostate cancer	1.2e-06	9.9e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—prostate cancer	1.2e-06	9.88e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.2e-06	9.88e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.19e-06	9.81e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.19e-06	9.79e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.19e-06	9.79e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—prostate cancer	1.19e-06	9.78e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.19e-06	9.77e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.19e-06	9.77e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.18e-06	9.73e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.18e-06	9.72e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—prostate cancer	1.18e-06	9.7e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.18e-06	9.69e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.18e-06	9.69e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.18e-06	9.69e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—prostate cancer	1.17e-06	9.66e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—prostate cancer	1.17e-06	9.65e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1.17e-06	9.64e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—prostate cancer	1.17e-06	9.63e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LPL—prostate cancer	1.17e-06	9.61e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—prostate cancer	1.17e-06	9.61e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.16e-06	9.53e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.15e-06	9.5e-06	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—prostate cancer	1.15e-06	9.49e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.15e-06	9.47e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—prostate cancer	1.15e-06	9.45e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.15e-06	9.44e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—prostate cancer	1.15e-06	9.44e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—prostate cancer	1.15e-06	9.44e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.15e-06	9.43e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.14e-06	9.42e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—prostate cancer	1.14e-06	9.41e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.14e-06	9.38e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.14e-06	9.36e-06	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—prostate cancer	1.14e-06	9.35e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.13e-06	9.28e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.13e-06	9.28e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.13e-06	9.26e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—prostate cancer	1.13e-06	9.26e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—NOS3—prostate cancer	1.12e-06	9.23e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.12e-06	9.23e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.12e-06	9.21e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.12e-06	9.2e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.12e-06	9.18e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.12e-06	9.18e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—NOS3—prostate cancer	1.11e-06	9.15e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.11e-06	9.09e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.09e-06	9.01e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—prostate cancer	1.09e-06	8.97e-06	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—prostate cancer	1.09e-06	8.95e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.09e-06	8.93e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—INS—prostate cancer	1.08e-06	8.91e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	1.08e-06	8.86e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—prostate cancer	1.07e-06	8.77e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.06e-06	8.76e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.06e-06	8.75e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.06e-06	8.73e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	1.05e-06	8.67e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.05e-06	8.65e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—prostate cancer	1.05e-06	8.63e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—prostate cancer	1.05e-06	8.61e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—prostate cancer	1.05e-06	8.61e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.05e-06	8.61e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.04e-06	8.59e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—prostate cancer	1.04e-06	8.58e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—prostate cancer	1.04e-06	8.57e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—prostate cancer	1.04e-06	8.55e-06	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.04e-06	8.54e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.04e-06	8.53e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.04e-06	8.52e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARA—prostate cancer	1.03e-06	8.49e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.03e-06	8.48e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.03e-06	8.45e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.03e-06	8.45e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.03e-06	8.44e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.03e-06	8.44e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.03e-06	8.44e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.03e-06	8.43e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.02e-06	8.43e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.02e-06	8.42e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—prostate cancer	1.02e-06	8.39e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.02e-06	8.37e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.01e-06	8.28e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1e-06	8.26e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	9.97e-07	8.2e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—prostate cancer	9.97e-07	8.2e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—prostate cancer	9.92e-07	8.16e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—prostate cancer	9.85e-07	8.1e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—prostate cancer	9.74e-07	8.01e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAV1—prostate cancer	9.7e-07	7.98e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—prostate cancer	9.69e-07	7.97e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—prostate cancer	9.69e-07	7.97e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—prostate cancer	9.67e-07	7.95e-06	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—prostate cancer	9.66e-07	7.95e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—prostate cancer	9.65e-07	7.94e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—prostate cancer	9.54e-07	7.85e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—prostate cancer	9.54e-07	7.85e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	9.52e-07	7.83e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NOS3—prostate cancer	9.5e-07	7.82e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	9.49e-07	7.81e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—prostate cancer	9.33e-07	7.68e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	9.33e-07	7.68e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—prostate cancer	9.12e-07	7.51e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—prostate cancer	9.08e-07	7.47e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	9.05e-07	7.44e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—prostate cancer	8.95e-07	7.36e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	8.9e-07	7.32e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	8.88e-07	7.31e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—prostate cancer	8.87e-07	7.3e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.83e-07	7.27e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—prostate cancer	8.83e-07	7.26e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	8.82e-07	7.25e-06	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—prostate cancer	8.8e-07	7.24e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—prostate cancer	8.77e-07	7.22e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—prostate cancer	8.75e-07	7.2e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	8.72e-07	7.17e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—prostate cancer	8.69e-07	7.15e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—prostate cancer	8.61e-07	7.09e-06	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—prostate cancer	8.61e-07	7.08e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—prostate cancer	8.59e-07	7.07e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—prostate cancer	8.53e-07	7.02e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—prostate cancer	8.46e-07	6.96e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—prostate cancer	8.43e-07	6.94e-06	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—prostate cancer	8.42e-07	6.93e-06	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—prostate cancer	8.37e-07	6.89e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—INS—prostate cancer	8.36e-07	6.88e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CREBBP—prostate cancer	8.19e-07	6.74e-06	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—prostate cancer	8.15e-07	6.7e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	8.1e-07	6.66e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—prostate cancer	8.01e-07	6.59e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—prostate cancer	7.91e-07	6.51e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—prostate cancer	7.88e-07	6.49e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—prostate cancer	7.87e-07	6.47e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—prostate cancer	7.83e-07	6.45e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.77e-07	6.39e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—prostate cancer	7.72e-07	6.35e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—prostate cancer	7.69e-07	6.32e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—prostate cancer	7.58e-07	6.24e-06	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—prostate cancer	7.39e-07	6.08e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NOS3—prostate cancer	7.33e-07	6.03e-06	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—prostate cancer	7.27e-07	5.98e-06	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—prostate cancer	7.26e-07	5.97e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—prostate cancer	7.23e-07	5.95e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—prostate cancer	7.17e-07	5.9e-06	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	7.12e-07	5.86e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.77e-07	5.57e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—prostate cancer	6.71e-07	5.52e-06	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	6.62e-07	5.44e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—prostate cancer	6.31e-07	5.19e-06	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—prostate cancer	6.28e-07	5.17e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.26e-07	5.15e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—prostate cancer	5.85e-07	4.81e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—prostate cancer	5.58e-07	4.59e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—prostate cancer	5.35e-07	4.4e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—prostate cancer	5.16e-07	4.24e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—prostate cancer	5.11e-07	4.21e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—prostate cancer	4.37e-07	3.59e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.13e-07	3.39e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—prostate cancer	3.37e-07	2.77e-06	CbGpPWpGaD
